These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1969854)
1. Analgesic, receptor binding, and peripheral opioid activities of synthetic dermorphin-dynorphin hybrid peptides. Ho CL; Ko JL; Hwang LL; Wang KT Int J Pept Protein Res; 1990 Feb; 35(2):99-104. PubMed ID: 1969854 [TBL] [Abstract][Full Text] [Related]
2. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays. Ho CL; Li CH Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148 [TBL] [Abstract][Full Text] [Related]
3. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens. Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735 [TBL] [Abstract][Full Text] [Related]
4. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group. Koike K; Takayanagi I; Hirakura Y; Matsueda R Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773 [TBL] [Abstract][Full Text] [Related]
5. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor. Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761 [TBL] [Abstract][Full Text] [Related]
6. Dermorphin interaction with peripheral opioid receptors. Giagnoni G; Parolaro D; Casiraghi L; Crema G; Sala M; Andreis C; Gori E Neuropeptides; 1984 Dec; 5(1-3):157-60. PubMed ID: 6099487 [TBL] [Abstract][Full Text] [Related]
7. Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion. Lazarus LH; Guglietta A; Wilson WE; Irons BJ; de Castiglione R J Biol Chem; 1989 Jan; 264(1):354-62. PubMed ID: 2562839 [TBL] [Abstract][Full Text] [Related]
8. The choice of opioid receptor subtype in isolated preparations by dynorphins. Oka T; Aoki K; Kajiwara M Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492 [TBL] [Abstract][Full Text] [Related]
9. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat. Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the receptor binding profile of (3H)-dermorphin in the rat brain. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Int J Pept Protein Res; 1988 Dec; 32(6):506-11. PubMed ID: 2907751 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist. Lemaire S; Turcotte A Can J Physiol Pharmacol; 1986 Jun; 64(6):673-8. PubMed ID: 2875777 [TBL] [Abstract][Full Text] [Related]
12. Opioid receptor binding profile of selected dermorphin-like peptides. Rossi AC; de Castiglione R; Perseo G Peptides; 1986; 7(5):755-9. PubMed ID: 2879276 [TBL] [Abstract][Full Text] [Related]
14. Dynorphin A(1-8): stability and implications for in vitro opioid activity. Bell KM; Traynor JR Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796 [TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of dermorphin, and [dermorphin1-7]-beta c-endorphin in rat brain membranes. Westphal M; Hammonds RG; Li CH Peptides; 1985; 6(1):149-52. PubMed ID: 2986079 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues. Yoshino H; Nakazawa T; Arakawa Y; Kaneko T; Tsuchiya Y; Matsunaga M; Araki S; Ikeda M; Yamatsu K; Tachibana S J Med Chem; 1990 Jan; 33(1):206-12. PubMed ID: 1967312 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and opioid activity of novel tetrapeptides analogous to sequence (1-4) of dermorphin. Naqvi T; Raghubir R; Haq W; Tripathi A; Patnaik GK; Mathur KB Neuropeptides; 1998 Aug; 32(4):333-8. PubMed ID: 10102678 [TBL] [Abstract][Full Text] [Related]
18. Central pharmacological activities and opiate receptor binding studies of some dermorphin analogs. Giagnoni G; Parolaro D; Crema G; Mennuni L; Brini A; Casiraghi L; Sala M; Gori E Peptides; 1985; 6 Suppl 3():155-9. PubMed ID: 3008117 [TBL] [Abstract][Full Text] [Related]
19. Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon. Giuliani S; Lecci A; Tramontana M; Maggi CA Br J Pharmacol; 1996 Nov; 119(5):985-9. PubMed ID: 8922749 [TBL] [Abstract][Full Text] [Related]
20. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]